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Summary  Panton-Valentine  leucocidin  (PVL)  is  a  pore-forming  toxin  that  has
been  epidemiologically  associated  with  CA-MRSA  infections.  However,  its  role  in
the  pathogenicity  of  Staphylococcus  aureus  is  still  unclear.  We  evaluated  the  preva-
lence  of  PVL-coding  genes  in  methicillin-resistant  (MRSA)  and  methicillin-sensitive
(MSSA)  isolates  that  cause  infections  in  pediatric  patients  in  the  city  of  Cartagena,
Colombia.  We  obtained  S.  aureus  isolates  from  patients  at  the  Napoleon  Franco
Pareja  Children’s  Hospital  in  Cartagena.  Then,  we  evaluated  the  presence  of  the
nuc,  mecA, and  PVL  genes  in  these  isolates  by  multiplex  PCR  and  determined  the
antibiotic  susceptibility  proﬁles  using  CLSI  standards.  We  further  correlated  methi-
cillin  susceptibility  and  the  presence  of  PVL  genes  with  clinical  variables.  Overall
PVL  prevalence  in  S.  aureus  isolates  was  73.91%,  with  a  frequency  of  80.92%  among
MRSA  isolates  and  67.59%  among  MSSA.  We  found  a  correlation  between  erythromycin
resistance  and  lack  of  PVL  and  found  that  PVL+  cases  were  more  common  in  older
patients.  We  found  a  high  PVL  prevalence  in  both  MRSA  and  MSSA  isolates,  in  con-
cordance  with  previous  regional  reports.
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Introduction
Staphylococcus  aureus  is a  major  human  pathogen
that causes  both  nosocomial  and  community-
acquired  infections,  which  range  from  skin  and
soft tissue  infections  to  osteomyelitis,  pneumonia,
bacteremia and  infections  associated  with  medi-
cal devices  [1]. Additionally,  S.  aureus  behaves  as
a commensal  bacterium,  colonizing  up  to  60%  of
healthy populations  [2]. In  Cartagena,  Colombia,  S.
aureus colonization  ranges  from  15.9  to  38.5%  [3,4],
depending on  the  study  population.
Both colonizing  and  pathogenic  potentials  of
S. aureus  are  related  to  the  virulence  factors
carried by  circulating  strains  [5—7]. High  preva-
lence of  Panton-Valentine  leucocidin  (PVL)  has
been documented  in  methicillin-resistant  isolates
of community  origin  (CA-MRSA)  [6]. PVL  is  a  pore-
forming  leukotoxin  composed  of  two  components,
S and  F,  which  are  encoded  by  the  LukS-PV  and
LukF-PV genes  in  the  lysogenic  phage  phiSLT  [8].
Due to  the  epidemiological  association  between
PVL and  CA-MRSA  isolates,  many  efforts  have  been
directed  toward  identifying  the  pathogenic  role  of
this toxin,  but  the  results  have  been  controversial.
Several in  vitro  studies  have  shown  that  PVL  induces
cell lysis  by  forming  pores  in  the  membranes  of
polymorphonuclear  cells  (PMNs),  and  it  induces
apoptosis by  interacting  with  the  mitochondrial
membrane [9]  and  activating  downstream  TLR-2
signaling  pathways,  leading  to  an  inﬂammatory
response [10]  and  complement  receptor-mediated
cytotoxicity  [11]. However,  animal  model  studies
have failed  to  demonstrate  a  pathogenic  role  for
PVL in  staphylococcal  infections  [12,13].  Despite
this  discrepancy,  PVL  has  been  increasingly  asso-
ciated  with  severe  clinical  manifestations  of  S.
aureus infections  [14—16];  thus,  more  research  is
still needed  to  identify  subjects  at  risk  for  develop-
ing severe  forms  of  infection  [17].
The prevalence  of  PVL  has  not  been  as  well-
studied in  MSSA  isolates  as  in  MRSA  isolates  [18].
However, it  has  been  determined  that  the  presence
of genes  encoding  PVL  varies  by  region,  and  there
is a  low  prevalence  in  countries  such  as  Spain  and
Portugal  and  higher  prevalence  reported  in  African
countries  [18]  and  Argentina  [19]. This  informa-
tion is important  for  regions  in  which  most  cases
of infections  by  PVL-positive  isolates  correspond  to
MSSA strains  [20].
In  this  study,  we  evaluated  the  prevalence  of  PVL
in both  MRSA  and  MSSA  S.  aureus  isolates  that  were
obtained  from  pediatric  infection  patients  in  the
regional children’s  hospital,  and  we  correlated  the
presence  of  the  PVL  virulence  factor  with  the  type
of infection  and  other  clinical  variables.
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aterials and methods
esign and study population
his  was  an  observational  cross-sectional  study
hat was  carried  out  at  the  Napoleon  Franco
areja Children’s  Hospital  in  Cartagena;  this  is  a
niversity-afﬁliated  pediatric  hospital  of  tertiary
are that  receives  patients  from  rural  and  urban
reas,  and  it  is  the  regional  referral  hospital.  The
thics committee  of  the  University  of  Cartagena
pproved this  study.  From  October  2009  to  June
012, S.  aureus  isolates  that  caused  laboratory-
onﬁrmed S.  aureus  infections  were  analyzed  in the
icrobiology  laboratory  of  the  Genetics  and  Molec-
lar Biology  Research  Group  of  the  University  of
artagena.  One  isolate  per  patient  was  included  in
he study,  and  we  reviewed  the  clinical  data  for
ach case  to  obtain  sociodemographic  information
nd infection  type.  Children’s  guardians  signed  an
nformed consent  allowing  us  to  use  the  information
or research.
acterial isolates
nly  one  isolate  per  case  was  included  in
he study;  isolates  were  conﬁrmed  by  standard
icrobiological  methods.  Using  the  disk  diffusion
ethod,  antibiotic  susceptibility  was  determined
ccording to  CLSI  standards  for  rifampicin  (5  g),
lindamycin  (2  g),  erythromycin  (15  g),  genta-
icin (10  g),  and  trimethoprim-sulfamethoxazole
1.25/23.75  g);  for  vancomycin,  the  minimum
nhibitory concentration  was  determined  using  the
gar dilution  test.  The  D test  was  used  to  detect
acrolide-inducible  resistance  to  clindamycin.
NA extraction and multiplex PCR assay
enomic  DNA  from  each  isolate  was  extracted  using
 modiﬁcation  of  the  method  developed  by  Mil-
ar et  al.  [21], as  we  have  previously  described
22]. Genomic  DNA  from  each  isolate  was  used  to
etermine  the  presence  of  nuc,  mecA,  and  lukS/F-
V genes  by  multiplex  polymerase  chain  reaction
ssay, according  to  protocols  that  we  have  pre-
iously  described  [22]. The  PCR  products  were
ubjected to  electrophoresis  in  a  1.5%  agarose  gel,
ollowed by  ethidium  bromide  staining  and  visual-
zation  using  UV  trans-illumination.
ata analysistatistical  analysis  was  performed  using  the  IBM
PSS software  for  Windows,  version  20.  According
o mecA  gene  presence,  the  isolates  were  classiﬁed
PVL  frequency  in  S.  aureus  causing  pediatric  infections
Table  1  General  characteristics  of  the  study  cases.
Characteristics  Number  (%)
N  =  276
Gender  Female  104  (37.68)
Male  172  (62.32)
Agea Neonates  14  (5.43)
Infants  34  (11.96)
Toddlers 38  (13.77)
Pre-schoolers 35  (12.68)
School  age 72  (26.09)
Adolescents  82  (29.71)
Type  SSTI  196  (71.01)
MSI  38  (13.77)
UTI  3  (1.09)
SSI  4  (1.45)
Pneumonia  7  (2.54)
Bacteremia  28  (10.14)
LukF-PV  Positive  204  (73.91)
Negative  72  (26.09)
MecA  Positive  131  (47.46)
Negative  145  (52.54)
a Neonates: ≤1 month old; infants: >1 month old to <1
year old; toddlers: ≥1 year old to 2 years old; pre-schoolers:
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M>2 years old to <5 years old; school age: 5 years old to <10
years old; adolescents ≥10 years old to <18 years old.
s  MRSA  or  MSSA  and  further  sub-classiﬁed  based
n the  presence  of  lukS/F-PV  genes  as  PVL-positive
r negative.  The  frequency  of  each  type  of isolate
as determined.  Descriptive  statistics,  including
istribution, central  tendency  and  dispersion,  were
alculated.  For  categorical  variables,  the  Fisher
xact  test  or  Pearson’s  Chi  Square  test  were  used
or comparisons.  We  considered  p  values  <0.05  to
e statistically  signiﬁcant.
esults
 total  of  276  cases  of  S.  aureus  infections  were
dentiﬁed during  the  study  period.  Of  these,  131
ere classiﬁed  as  MRSA  infections,  and  145  were
SSA.  Table  1  summarizes  the  general  character-
stics of  the  cases  included  in  the  study.  Most  of
he study  population  consisted  of  school-age  and
dolescent  patients.  Skin  and  soft  tissue  infections
ere the  most  frequent,  followed  by  musculoskele-
al infections.  Overall,  204  isolates  (73.91%)  had
VL genes;  80.92%  of  MRSA  isolates  but  only  67.59%
f MSSA  isolates  were  PVL-positive  (p  =  0.0135).
able  2 summarizes  the  differences  between  MRSA
nd MSSA  isolates.  When  we  perform  the  same  anal-
sis for  cases  of  MRSA  infections  with  or  without
VL, we  found  no  statistically  signiﬁcant  differ-
nces  in  gender,  age  or  type  of  infection  (data  not
hown).  In  contrast,  we  found  that  patients  with
M
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SSA  infections  due  to  PVL+  strains  were  older
p =  0.0013,  data  not  shown).
Resistance  proﬁles  are  shown  in  Table  3. Resis-
ance to  erythromycin  was  associated  with  a lack
f PVL  in  the  isolates;  23.61%  of  the  PVL-negative
solates were  resistant  to  this  antibiotic  com-
ared with  9.31%  PVL-positive  isolates.  When  we
ompared  methicillin  resistance  in  PVL-positive
nd negative  strains  (see  Table  4),  we  conﬁrmed
he relationship  between  erythromycin  resistance
nd the  lack  of  PVL  genes  in  the  MSSA  iso-
ates (p  =  0.0007).  No  other  association  between
ntibiotic resistance  and  PVL  presence  was  found.
nly one  isolate  was  positive  in  the  D-test,
nd a different  isolate  showed  resistance  to
rimethoprim-sulfamethoxazole.
iscussion
ne  of  the  most  important  determinants  of  the
everity  and  outcome  of  any  infection  is  the  pres-
nce of  virulence  factors  in  the  infectious  agent.
ultiple  virulence  factors  have  been  associated
ith the  pathogenic  potential  of  S.  aureus  [6,7].
f these  factors,  PVL  has  been  the  most  studied.
here is  historical,  epidemiological  and  biochemi-
al evidence  that  supports  the  implication  of  this
oxin in  the  pathogenesis  of  S.  aureus;  however,  it
s unclear  whether  PVL  affects  the  presentation  or
everity of  infection  [17]. Most  studies  have  found
 strong  epidemiological  association  between  PVL
nd infections  caused  by  CA-MRSA.  In  this  study,
he prevalence  of  MRSA  isolates  carrying  PVL  genes
as 80.92%,  which  is  similar  to  data  previously
escribed in  different  geographical  latitudes  [23].
In Colombia,  the  reported  prevalence  of  PVL  in
RSA isolates  ranges  from  73  to  98.7%.  Jimenez
t al.  found  that  73%  of  MRSA  isolates  obtained  from
ediatric infections  in  Medellin  were  positive  for
VL [24]. Meanwhile,  it was  reported  in  the  city  of
ucaramanga  that  88%  of MRSA  isolates  obtained
rom patients  of  the  same  age  were  positive  for
VL [25]. In  Bogota,  Marquez-Ortiz  et  al.  deter-
ined that  98.7%  of  the  community-acquired  MRSA
solates that  caused  pediatric  infections  were  pos-
tive for  PVL  [26]. One  plausible  explanation  for
his higher  frequency  than  that  reported  by  our
roup  is that  our  study  population  was  larger,  and
esearchers  only  focused  on  community-acquired
RSA  isolates.
Less data  are  available  on  PVL  prevalence  in
SSA isolates  compared  with  MRSA  isolates.  There
re reports  of  frequencies  lower  than  1%  in  northern
pain  [27],  lower  than  20%  in  Turkey  [28], Greece
418  O.  Correa-Jiménez  et  al.
Table  2  Differences  between  MRSA  and  MSSA  isolates.
MRSA  MSSA  p  value
Number  (%)  Number  (%)
N  =  131  N  =  145
Gender  Female  53  (40.46)  51  (35.17)  0.3859
Male  78  (59.54) 94  (64.83)
Agea Neonates  8  (6.11) 6  (4.83) 0.2097
Infants  15  (11.45) 19  (12.41)
Toddlers  25  (19.08)  13  (8.96)
Pre-School  16  (12.21)  19  (13.10)
School  age  31  (23.66)  41  (28.27)
Adolescents  35  (27.72)  47  (32.41)
Type  SSTIb 95  (72.52)  105  (72.41)  0.8997
MSI  19  (14.50)  19  (13.10)
Invasive  17  (12.98)  21  (14.48)
LukF-PV  Positive  106  (80.92)  98  (67.59)  0.0135
Negative  25  (19.08)  47  (32.41)
a Neonates: ≤1 month old; infants: >1 month old to <1 year old; toddlers: ≥1 year old to 2 years old; pre-schoolers: >2 years
old to <5 years old; school age: 5 years old to <10 years old; adolescents ≥10 years old to <18 years old.
b For analysis purposes, SSTI also included surgical wound infections, and invasive infections included pneumonia, urinary tract
infections and bacteremia. p values from Fisher’s exact test.
Table  3  Antimicrobial  resistance  proﬁles.
General  PVL+  PVL− p
N  =  276  N  =  204  N  =  72
Gentamicin  5  (1.81)  4  (1.96)  1  (1.39)  1.0000
Erythromycin  36  (13.04)  19  (9.31)  17  (23.61)  0.0038
Clindamycin  14  (5.07)  11  (5.39)  3  (4.17)  1.0000
D  test  1  (0.36)  1  (0.49)  0
Trimethoprim/Sulfamethoxazole  1  (0.36)  0  1  (1.39)
Rifampicin  0  0  0
Vancomycin  0  0  0
riate.p values were obtained from Fisher’s exact test where approp
[29]  and  Lebanon  [30]; and  above  40%  in  India  [31],
Nepal [32]  and  Africa  [33].  More  recently,  Bazzi
et al.  described  a  30%  prevalence  of  PVL  genes  in
MSSA isolates  [18].
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Table  4  Antimicrobial  resistance  differences  between  MRS
General  MRSA  
N  =  276  PVL+  PVL− 
N  =  106  N  =  25  
Gentamicin  5  (1.81)  3  (2.83)  1  (4.00)  
Erythromycin  36  (13.04)  17  (16.04)  8  (32.00)  
Clindamycin  14  (5.07)  8  (7.55)  0  (0)  
D  test  1  (0.36)  1  (0.94)  0  (0)  
TMP/SMX  1  (0.36)  0  (0)  1  (4.00)  
Rifampicin  0  (0)  0  (0)  0  (0)  
Vancomycin 0  (0)  0  (0)  0  (0)  
p values were obtained using Fisher’s exact test where appropriat
inhibitory concentration for vancomycin was not evaluated in MSSAIn  this  study,  we  report  a 67.59%  prevalence
f PVL  genes  in  MSSA  isolates.  To  our  knowledge,
his is  one  of  the  highest  reported  frequencies  of
VL genes  in  this  type  of  isolate,  higher  than  any
A  and  MSSA  isolates.
MSSA
p  PVL+  PVL− p
N  =  98  N  =  47
0.5760  1  (1.02)  0  (0)
0.0888  2  (2.04)  9  (19.14)  0.0007
3  (3.06)  3  (6.38)  0.3895
0  (0)  0  (0)
0  (0)  0  (0)
0  (0)  0  (0)
NE  NE
e. TMP/SMX: trimethoprim/sulfamethoxazole. The minimum
 isolates.
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[VL  frequency  in  S.  aureus  causing  pediatric  infect
revious  reports  in  our  country  [24]  and  only
xceeded by  the  81.1%  reported  in  Mozambique
y van  der  Meeren  et  al.  [34].  Finding  a high
revalence of  PVL  genes  among  MSSA  isolates  lends
upport  to  the  hypothesis  that  the  origin  of  the
redominant MRSA  clone  in  Colombia  is  from  a
SSA-derived  clone  [35]  that  already  harbored  the
VL genes.
An association  between  PVL  presence  in  MSSA
solates and  resistance  to  trimethoprim  sul-
amethoxazole has  been  described  [18].  However,
hen we  tested  antibiotic  susceptibility,  we  only
ound an  association  between  PVL  and  lack  of resis-
ance to  erythromycin  in  MSSA  isolates.
onclusions
n  this  study,  we  found  a  high  prevalence  of  PVL
enes in  MRSA  and  MSSA  isolates.  The  observed
revalence of  PVL  genes  in  MSSA  isolates  is  one
f the  highest  reported.  This  ﬁnding  supports  the
ypothesis  that  the  major  circulating  MRSA  clone
n Colombia  may  have  originated  from  a  MSSA  iso-
ate. To  test  this  hypothesis,  it  will  be  necessary
o study  these  isolates  phylogenetically  to  deter-
ine the  genetic  relatedness  between  MRSA  and
SSA isolates.  Additionally,  we  found  no  associa-
ion between  the  type  of  infection  and  presence  of
VL genes  in  the  isolates.  Longitudinal  studies  with
lose clinical  monitoring  will  be  needed  to  identify
uch relationships.
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